Aberdeen Group’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.2M | Buy |
501,056
+22,152
| +5% | +$805K | 0.03% | 440 |
|
|
2025
Q1 | $17.3M | Buy |
478,904
+161,779
| +51% | +$5.86M | 0.03% | 432 |
|
|
2024
Q4 | $13.3M | Buy |
317,125
+63,821
| +25% | +$2.68M | 0.03% | 450 |
|
|
2024
Q3 | $14.1M | Sell |
253,304
-31,441
| -11% | -$1.75M | 0.03% | 456 |
|
|
2024
Q2 | $11.7M | Buy |
284,745
+143,628
| +102% | +$5.9M | 0.02% | 483 |
|
|
2024
Q1 | $6.59M | Hold |
141,117
| – | – | 0.01% | 621 |
|
|
2023
Q4 | $6.75M | Buy |
+141,117
| New | +$6.75M | 0.01% | 620 |
|